Director · CAPRICOR THERAPEUTICS, INC. · CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
61.3K
Price
—
Executed
Mar 31, 2026
Disclosed
Apr 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 31 executedApr 1, 2026 disclosed
CAPR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)
Ticker
CAPR
Shares
61.3K
Price per share
$0
Execution date (reported)
Mar 31, 2026
Owned after transaction
53.7K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
1
What this establishes
Sabar Karimah Es filed this Form 4 reporting a option exercise of CAPR on Mar 31, 2026. It became public on Apr 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Sabar Karimah Escik:0001873796
Issuer
CAPRICOR THERAPEUTICS, INC.cik:0001133869
Revision history · 0
No field has changed since this record was first ingested.
